SCSC

AI Memo

ScanSource

As of 2026-10-20/Confidence medium/Horizon 6‑12m

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-10-20 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

—

Confidence

medium

Horizon

6‑12m

Key catalyst

MicroAge integration and revised outlook • 2027-06-30

Base target: $65 / p=50% prob

Biggest risk

Q4 gross-margin compression, acquisition integration costs and roughly $225 million of new borrowing could outweigh sales growth. The FY27 guidance excludes MicroAge, so it does not establish combined-company earnings power. [#SEC-8K-2026-08-20] [#8-K-2026-09-02]

Invalidation

Break below $47 or thesis failure.

What would change my mind?

Q4 hardware-led sales growth and higher EPS provide operating momentum; FY27 organic guidance leaves potential upside if demand persists and MicroAge adds higher-margin services. [#SEC-8K-2026-08-20]

Research note

Recommendation

—

Confidence

medium

As of

2026-10-20

Base target

$65

p=50%

Bull target

$73

p=30%

Bear target

$47

p=20%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

FY27 organic growth outlook
Hardware growth versus gross-margin pressure
Q4 hardware-led sales growth and higher EPS provide operating momentum; FY27 organic guidance leaves potential upside if demand persists and MicroAge adds higher-margin services.

BearKey bullets

Channel demand, supplier terms, tariffs and partner credit exposure could weaken results.
[#SEC-8K-2026-08-20]
FY27 guidance excludes MicroAge; combined-company forecasts and realized synergies remain uncertain.

WatchKey bullets

MicroAge integration and revised outlook

Summary

High-level snapshot

Recommendation

Model confidence

medium

Timeframe

6‑12m

Asset

Equity

Trigger

Base case: $65 (p=50%)

Target spread vs base: +13% / -27%

Scenario probabilities

Bull Target: $73 (p=30%)Base Target: $65 (p=50%)Bear Target: $47 (p=20%)

Commentary

The company-reported Q4 growth and completed acquisition support a constructive tone, but the available post-print analyst-revision evidence is insufficient. The $59.28 anchor is above the $58.71 price cited in an October 1 secondary article; that comparison is not a verified earnings-day reaction. Social, options, short-interest and employee measures were unavailable, so their zero entries are placeholders rather than neutral readings.

As of 2026-10-20 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Q4 hardware-led sales growth and higher EPS provide operating momentum; FY27 organic guidance leaves potential upside if demand persists and MicroAge adds higher-margin services. [#SEC-8K-2026-08-20]

Bear Case

Drivers

Scannable catalysts and supporting factors

FY27 organic growth outlook
Hardware growth versus gross-margin pressure

Scenarios

Bull Target (Scenario probability)

$73 / p=30% prob

Base Target (Scenario probability)

$65 / p=50% prob

Bear Target (Scenario probability)

$47 / p=20% prob

Analysis 2026-10-20 · RankAlpha Sentiment Codex

Analysis reference price unavailable. Targets are shown without scenario returns.

Sentiment & Exposure

News Sentiment (30d)

0.20

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2027-06-30
MicroAge integration and revised outlook
The September 1 MicroAge closing added solutions and services capabilities, but required approximately $225 million of revolving-credit borrowing. Evidence of acquired contribution, margins and cash conversion—not merely the closing—will determine whether the deal adds value. [#8-K-2026-09-02] SEC closing filing
Prob 55.00% • Move 8.00% • Priced-in 35.00%

Short-term Catalysts

Next few weeks

FY27 organic growth outlook
2027-06-30
ScanSource guided to 6%–10% FY27 sales growth, $158 million–$165 million adjusted EBITDA and at least $85 million free cash flow, explicitly excluding MicroAge. Sustained hardware demand would support the outlook, but delivery remains unproven. [#SEC-8K-2026-08-20] SEC earnings exhibit
Prob 65% • Move 6% • Priced-in 45%

Long-term Catalysts

Months to a year

Hardware growth versus gross-margin pressure
2027-06-30
Q4 FY26 sales rose 17.3% and GAAP diluted EPS rose to $1.24, while gross margin fell to 12.6% from 12.9%. Continued volume growth without further margin erosion would strengthen the earnings case. [#SEC-8K-2026-08-20] SEC earnings exhibit
Prob 60% • Move 5% • Priced-in 50%

Risks

Channel demand, supplier terms, tariffs and partner credit exposure could weaken results. [#SEC-8K-2026-08-20]
FY27 guidance excludes MicroAge; combined-company forecasts and realized synergies remain uncertain. [#SEC-8K-2026-08-20]
MicroAge integration and acquisition-funded debt may pressure interest expense and cash conversion. [#8-K-2026-09-02]
Q4 FY26 gross margin fell 35 basis points year over year despite 17.3% sales growth. [#SEC-8K-2026-08-20]

Peers

Symbol	Summary
AVT	Avnet offers a distribution-cycle reference, but its electronic-components focus makes it a less direct margin comparable.
CDW	CDW provides a useful IT-solutions and distribution comparison, though its customer and services mix differs from ScanSource's.
INGM	Ingram Micro is a closer IT-distribution operating comparison than broad hardware manufacturers; differences in mix and scale limit a direct valuation read-through.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-10-20

Loading AI feed…

Symbol

Summary

AVT

Avnet offers a distribution-cycle reference, but its electronic-components focus makes it a less direct margin comparable.

CDW

CDW provides a useful IT-solutions and distribution comparison, though its customer and services mix differs from ScanSource's.

INGM

Ingram Micro is a closer IT-distribution operating comparison than broad hardware manufacturers; differences in mix and scale limit a direct valuation read-through.